INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
SZNOL, M [1 ]
PARKINSON, DR [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,CANC THERAPY EVALUAT PROGRAM,INVEST DRUG BRANCH,EPN 715,ROCKVILLE,MD 20852
来源：
BLOOD | 1994年 / 83卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2020 / 2022
页数：3
相关论文
共 50 条
  • [41] INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELL THERAPY - ANALYSIS OF A BOLUS INTERLEUKIN-2 AND A CONTINUOUS INFUSION INTERLEUKIN-2 REGIMEN
    CLARK, JW
    SMITH, JW
    STEIS, RG
    URBA, WJ
    CRUM, E
    MILLER, R
    MCKNIGHT, J
    BEMAN, JA
    STEVENSON, HC
    CREEKMORE, S
    STEWART, M
    CONLON, K
    SZNOL, M
    KREMERS, P
    COHEN, P
    LONGO, DL
    CANCER RESEARCH, 1990, 50 (22) : 7343 - 7350
  • [42] Interleukin-2 (IL-2) post high dose chemotherapy mobilized autologous stem cell transplant (ASCT) for hematologic malignancies.
    Oliveira, JSR
    Cecyn, KZ
    Parisio, K
    Faria, JR
    Ribeiro, MSS
    Chauffaille, MDLF
    Raineri, G
    BLOOD, 2001, 98 (11) : 396B - 397B
  • [43] Interleukin-10 and phenomena of tolerance in interleukin-2 therapy
    Engelhardt, M
    Brennscheidt, U
    Mertelsmann, R
    Lindemann, A
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 364 - 364
  • [44] INTERLEUKIN-2 AND THE INTERLEUKIN-2 RECEPTOR COMPLEX
    GAULTON, GN
    WILLIAMSON, P
    LYMPHOCYTE ACTIVATION, 1994, 59 : 91 - 114
  • [45] CORTICOSTEROID INTERLEUKIN-2 INTERACTIONS - INHIBITION OF BINDING OF INTERLEUKIN-2 TO INTERLEUKIN-2 RECEPTORS
    HORST, HJ
    FLAD, HD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 68 (01): : 156 - 161
  • [46] HEMATOLOGIC EFFECTS OF LOW-DOSE CONTINUOUS INFUSION INTERLEUKIN-2 WITH CONCOMITANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC SOLID MALIGNANCIES
    DAVE, HPG
    WHITE, C
    SCHULOF, R
    AVIS, FP
    CLINICAL RESEARCH, 1991, 39 (02): : A430 - A430
  • [47] INTERLEUKIN-2 THERAPY FOR METASTATIC UVEAL MELANOMA
    DORVAL, T
    FRIDMAN, WH
    MATHIOT, C
    POUILLART, P
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 2087 - 2087
  • [48] TRANSIENT PROTEINURIA DURING INTERLEUKIN-2 THERAPY
    BASTUJIGARIN, S
    CHOSIDOW, O
    LANG, P
    ROUJEAU, JC
    REVUZ, J
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (08) : 924 - 925
  • [49] Interleukin-2 therapy for HIV+ individuals
    Jacobson, EL
    Pilaro, FM
    Smith, KA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A250 - A250
  • [50] The future role of interleukin-2 in cancer therapy
    Lotze, MT
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 2000, 6 : S58 - S60
12345